CANDEL THERAPEUTICS, INC. Conversion of Stock, Shares Converted
CANDEL THERAPEUTICS, INC. (CADL) reported Conversion of Stock, Shares Converted of 7.07 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-29.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2022-03-29
- CANDEL THERAPEUTICS, INC. conversion of stock, shares converted for the quarter ending 2021-12-31 was 0.00 shares.
- CANDEL THERAPEUTICS, INC. conversion of stock, shares converted for the quarter ending 2021-09-30 was -1.00 shares.
- CANDEL THERAPEUTICS, INC. conversion of stock, shares converted for fiscal 2021 was 7.07M shares.
| Period end | Conversion of Stock, Shares Converted 3 month | Conversion of Stock, Shares Converted 6 month | Conversion of Stock, Shares Converted 9 month | Conversion of Stock, Shares Converted 12 month |
|---|---|---|---|---|
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -1.00 shares derived: sum of 2 quarters · filed 2022-03-29 | 7.07M shares 10-K · filed 2022-03-29 | |
| 2021-09-30 | -1.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | 7.07M shares 10-Q · filed 2021-11-12 | ||
| 2021-06-30 | 7.07M shares 10-Q · filed 2021-09-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |